NLS Pharmaceutics AG (NLSP) - שולי הרווח הגולמי

NLSP (NLS Pharmaceutics) - סמל מסחרי של החברה

Relative gross margin demonstrates the potential of Quilience, which targets narcolepsy via an innovative dopamine mechanism, while 0.00 serves as the current parameter value. Current financial health is based on capital reserves, as the clinical testing stage precludes operational cash flow. The authority of NLS Pharmaceutics AG (NLSP) in treating rare cognitive disorders helps patients return to their normal rhythm of life.

NLSP - רווחיות גולמית NLS Pharmaceutics Ltd. בטווח 04.07.2022 - 31.10.2025

פילוחי מדדים מקיפים ואנליטיקה עבור NLS Pharma (NLSP)

- מחיר שוק ויעדי מחיר של אנליסטים:
ניתוח בסיסי של החברה:NLS Pharmaceutics AG NLSP
מוצר סדרתי של NLS Pharmaceutics Ltd.

Gross margin measures the efficiency of direct production by determining the profit share after deducting the cost of goods sold. Gross margin dynamics allow an investor to promptly assess the profitability of operational processes and the risk of an overvalued asset. This ratio is calculated as the difference between revenue and production costs divided by total sales, which is critically important for evaluating the R&D potential of NLS Pharmaceutics AG (NLSP) in developing medications for the treatment of ADHD.